Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors

Overview of attention for article published in Arthritis & Rheumatology, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet
twitter: 18 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 71 Mendeley

So far, Altmetric has seen 24 X posts from 18 X users, with an upper bound of 32,854 followers.

Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors https://t.co/O7tj1OZdne

MDACCから irAEs-筋炎の報告・ICI使用の9088中, 36(0.4%)でirAEs-筋炎発症・ICI 2剤併用の方が単剤使用より3倍程度risk↑ ・約半数は筋炎単独だが, 残り半数は心筋炎 and/or MGのoverlap ・死亡した8人は全てoverlap ・7割程度でsteroid + αを使用 (BioはRTX, IFX, TCZ) htt…

RT @ACR_Journals: Just accepted in Arthritis & Rheumatology: Inflammatory myositis in cancer patients receiving immune checkpoint inhibito…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 20 additional X posts.